Nutropin [Somatropin (rDNA origin) for injection]
ApprovedWithdrawn 0 watching 0 views this week🔥 Hot
82
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Idiopathic Short Stature
Conditions
Idiopathic Short Stature
Trial Timeline
May 1, 2013 → May 31, 2013
NCT ID
NCT01438801About Nutropin [Somatropin (rDNA origin) for injection]
Nutropin [Somatropin (rDNA origin) for injection] is a approved stage product being developed by Ipsen for Idiopathic Short Stature. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT01438801. Target conditions include Idiopathic Short Stature.
Hype Score Breakdown
Clinical
30
Activity
20
Company
7
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01438801 | Approved | Withdrawn |
Competing Products
20 competing products in Idiopathic Short Stature